BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
PRKCA
,
Angiogenesis
,
Influenza
,
Stem cell
,
Hematopoietic cell
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Friedreich ataxia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
FRDA2
FXN
HBG1
HBG2
POU5F1P3
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MANALO_HYPOXIA_DN
GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP
FISCHER_DREAM_TARGETS
PUJANA_BRCA1_PCC_NETWORK
DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Friedreich’s ataxia induced pluripotent stem cells
Neural progenitors from Friedreich ataxia patient iPSCs (induced pluripotent stem cells)
PBMC of Friedreich's Ataxia patients and controls after in vitro treatment with HDAC inhibitors
Lymphocytes of Friedreich's ataxia patients treated with nicotinamide
OMIM - Ataxia
Explore Curated Studies Results
Literature
Most Relevant Literature
Nerve ultrasound in Friedreich's Ataxia: enlarged nerves as a biomarker of disease severity.
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data.
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI-1601) in Friedreich's ataxia.
Quantitative Assessment of Friedreich Ataxia via Self-Drinking Activity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Friedreich's Ataxia
EPI-743 in Friedreich's Ataxia Point Mutations
Methylprednisolone Treatment of Friedreich Ataxia
Rosuvastatin (Crestor) in Friedreich Ataxia
Biomarker for Friedreich's Ataxia (BioFridA)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ